Already have an ACS ID? Log in
Renew your membership, and continue to enjoy these benefits.
Already an ACS Member? Log in here
Choose the membership that is right for you. Discount will be applied automatically at checkout.
Enjoy these benefits no matter which membership you pick.
Most Popular in Pharmaceuticals
The contract chemistry research company Naeja Pharmaceutical will receive $10.2 million from AstraZeneca Canada under a three-year research partnership focused on accelerating the development of novel pain-control compounds. Naeja, based in Edmonton, Alberta, says it will work with chemists at AstraZeneca's Montreal drug discovery center in preclinical discovery and development. Naeja employs more than 100 scientists, 80 of whom hold Ph.D.s; it says the agreement will create 20 new jobs.
This article has been sent to the following recipient: